Molutrex

potassium hydroxide 5% solution · Laboratoire Dermatologique ACM

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Molutrex, covering 2024-05-29 to 2024-05-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of a Cohort of Children With Molluscum Contagiosum (MC) Treated With a 5% Solution of Potassium Hydroxide (Molutrex®) Applied Locally to the Skin

See pricing